Surrogate markers: The AIDS clinical trials

被引:0
|
作者
Mildvan, D
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:1233 / 1234
页数:2
相关论文
共 50 条
  • [11] SURROGATE MARKERS IN AIDS - IN RESPONSE
    LAGAKOS, S
    HOTH, DF
    ANNALS OF INTERNAL MEDICINE, 1992, 117 (07) : 619 - 619
  • [12] Use of Surrogate Versus Clinical Markers in Trials for HIV Infection
    Scott Hammer
    Drug information journal : DIJ / Drug Information Association, 1999, 33 (2): : 347 - 352
  • [13] Use of surrogate versus clinical markers in trials for HIV infection
    Hammer, S
    DRUG INFORMATION JOURNAL, 1999, 33 (02): : 347 - 352
  • [14] An approach to the validation of markers for use in AIDS clinical trials
    Mildvan, D
    Landay, A
    DeGruttola, V
    Machado, SG
    Kagan, J
    CLINICAL INFECTIOUS DISEASES, 1997, 24 (05) : 764 - 774
  • [15] Virologic and regimen termination surrogate end points in AIDS clinical trials
    Gilbert, PB
    DeGruttola, V
    Hammer, SM
    Kuritzkes, DR
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (06): : 777 - 784
  • [16] Validation of surrogate markers in multiple randomized clinical trials with repeated measurements
    Alonso, A
    Geys, H
    Molenberghs, G
    Kenward, MG
    Vangeneugden, T
    BIOMETRICAL JOURNAL, 2003, 45 (08) : 931 - +
  • [17] LABORATORY MARKERS AS POTENTIAL SURROGATES FOR CLINICAL OUTCOMES IN AIDS TRIALS
    MOSS, AR
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1990, 3 : S69 - S71
  • [18] Biomarkers as surrogate endpoints in clinical trials for HIV/AIDS: a model for other diseases?
    Mildvan, D
    BIOMARKERS AND SURROGATE ENDPOINTS: CLINICAL RESEARCH AND APPLICATIONS, 2000, 1205 : 13 - 17
  • [19] Surrogate markers in AIDS research - Is there truth in numbers?
    Levy, JA
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (02): : 161 - 162
  • [20] Surrogate Endpoints in Clinical Trials
    Elliott, Michael R.
    ANNUAL REVIEW OF STATISTICS AND ITS APPLICATION, 2023, 10 : 75 - 96